Abiopharma

🔍 LOZANO MONICA C (Director)

Company: BANK OF AMERICA CORP /DE/ (BAC)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-04 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 3,387.00
• Acquired 5,365 shares of Phantom Stock (Derivative)
  Date: 2026-05-04 | Code: A | equity_swap_involved: 0 | shares_owned_after: 246,347.52 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2, F3

Footnotes:

• F1: Each phantom stock unit is the economic equivalent of one share of Bank of America Corporation common stock.
• F2: Phantom stock units acquired represent payment of annual compensation for services as a director under the Bank of America Corporation Director Deferral Plan in transactions exempt under Rule 16b-3. Phantom stock units may be settled in cash upon death or termination of service as a director.
• F3: Includes 5,188.86 phantom stock units acquired in dividend reinvestment transactions under the Bank of America Corporation Director Deferral Plan.